share

α-Cgrp (8-37) (Rat) CAS NO 129121-73-9


Unit Price:

CAS No.:129121-73-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

α-Cgrp (8-37) (Rat) is a synthetic peptide fragment corresponding to residues 8-37 of the rat calcitonin gene-related peptide (CGRP) alpha isoform. This compound serves as a potent and selective antagonist of the CGRP receptor, making it a critical tool for neurological and cardiovascular research. It is primarily utilized by pharmaceutical R&D teams, academic researchers, and contract research organizations (CROs) investigating migraine pathways, neurogenic inflammation, and vascular biology.

Application

  • Neuroscience Research: Used as a selective CGRP receptor antagonist to study the role of CGRP in migraine pathophysiology, pain transmission, and neurogenic inflammation.
  • Cardiovascular Studies: Employed in preclinical models to investigate CGRP-mediated vasodilation, blood pressure regulation, and vascular tone.
  • Drug Discovery & Development: Serves as a reference standard and pharmacological tool for screening and validating novel CGRP-targeted therapeutics for migraine and other disorders.
  • Academic & Institutional Research: A key reagent for in vitro (cell-based assays) and in vivo (animal model) studies exploring CGRP signaling pathways.
  • Biochemical Assay Development: Used to establish competitive binding assays (e.g., receptor binding, ELISA) to quantify CGRP activity or antagonist potency.

Basic Information

Product Name α-Cgrp (8-37) (Rat)
CAS No. 129121-73-9
Molecular Formula C142H244N46O41S
Molecular Weight 3203.8 g/mol
Synonyms α-CGRP (8-37), rat; Calcitonin Gene-Related Peptide (8-37), rat alpha; CGRP-(8-37), rat; rCGRPα-(8-37); α-Calcitonin Gene-Related Peptide Fragment 8-37 (Rat); CGRP receptor antagonist (rat); Tyr-Ser-Phe-Gly-Val-Val-Thr-Asp-Val-Phe-His-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2 (rat sequence)
EINECS Contact for details

Quality Control

Our α-Cgrp (8-37) (Rat) is manufactured under strict quality systems to ensure batch-to-batch consistency and reliability for research. Each lot undergoes comprehensive analytical testing, including HPLC for purity assessment and MS for identity confirmation. A detailed Certificate of Analysis (COA) is provided, documenting purity, peptide content, and solvent residues. We support research requiring compliance with cGMP guidelines for non-clinical materials.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store desiccated at -20°C or below. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a dry environment before opening to minimize moisture uptake.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (HPLC/MS) Conforms to reference standard
Purity (HPLC) ≥ 95%
Peptide Content ≥ 80% (by weight)
Single Impurity (HPLC) ≤ 1.0%
Water Content (KF) ≤ 5.0%
Acetate Content (HPLC/IC) ≤ 10.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.